Explore / Clinical trial
Clinical trial

Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)

Resilient PharmaceuticalsCompletedPhase 2Started Mar 13, 20184 enrolledCanadaNCT03485287

Abstract

The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective at reducing PTSD symptoms in people with at least severe PTSD. The main question it aims to answer is: Do three open-label sessions of MDMA-assisted therapy reduce PTSD symptoms? Participants will receive three non-drug preparatory sessions followed by three sessions of MDMA-assisted therapy. Each MDMA-assisted therapy session is followed by three non-drug integrative therapy sessions.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMAPTSD

Keywords

TherapyPosttraumatic Stress Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.